Optimal Management of CML without Breaking the Bank
This information was originally presented on September 19, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Identify the challenges associated with the selection of appropriate first-line therapy TKI for the optimal management of patients with CML
Neil P. Shah, MD, PhD
UCSF Helen Diller Family Comprehensive Cancer Center
- 0.75 Participation
- 0.63 Nurse
- 0.75 Pharmacist
- 0.75 Physician